- Home
- TNON vs PTPI Comparison
TNON vs PTPI Comparison
Compare TNON & PTPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNON
- PTPI
- Stock Information
- Founded
- TNON 2012
- PTPI 2020
- Country
- TNON United States
- PTPI United States
- Employees
- TNON N/A
- PTPI N/A
- Industry
- TNON Medical Specialities
- PTPI Biotechnology: Pharmaceutical Preparations
- Sector
- TNON Health Care
- PTPI Health Care
- Exchange
- TNON Nasdaq
- PTPI Nasdaq
- Market Cap
- TNON 3.2M
- PTPI 2.6M
- IPO Year
- TNON 2022
- PTPI N/A
- Fundamental
- Price
- TNON $1.47
- PTPI $0.07
- Analyst Decision
- TNON Strong Buy
- PTPI
- Analyst Count
- TNON 2
- PTPI 0
- Target Price
- TNON $16.00
- PTPI N/A
- AVG Volume (30 Days)
- TNON 21.4M
- PTPI 96.0M
- Earning Date
- TNON 05-13-2025
- PTPI 05-14-2025
- Dividend Yield
- TNON N/A
- PTPI N/A
- EPS Growth
- TNON N/A
- PTPI N/A
- EPS
- TNON N/A
- PTPI N/A
- Revenue
- TNON $3,277,000.00
- PTPI $5,112,043.00
- Revenue This Year
- TNON $118.16
- PTPI N/A
- Revenue Next Year
- TNON $7.40
- PTPI $0.76
- P/E Ratio
- TNON N/A
- PTPI N/A
- Revenue Growth
- TNON 11.92
- PTPI N/A
- 52 Week Low
- TNON $0.91
- PTPI $0.05
- 52 Week High
- TNON $15.79
- PTPI $1.03
- Technical
- Relative Strength Index (RSI)
- TNON 47.64
- PTPI 41.43
- Support Level
- TNON $2.01
- PTPI $0.06
- Resistance Level
- TNON $3.26
- PTPI $0.11
- Average True Range (ATR)
- TNON 0.50
- PTPI 0.02
- MACD
- TNON 0.03
- PTPI 0.01
- Stochastic Oscillator
- TNON 11.34
- PTPI 10.23
About TNON Tenon Medical Inc.
Tenon Medical Inc is a medical device company that has developed a novel, minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities: 1) Primary SI Joint procedures, 2) Revision procedures of failed SI Joint implants, and 3) SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.
About PTPI Petros Pharmaceuticals Inc.
Petros Pharmaceuticals Inc is a men's health pharmaceutical company. It focuses on therapeutics that promote medication adherence, tolerability, and preservation of male organic function. The company's operating segment includes Prescription Medications and Medical Devices. It generates maximum revenue from the Medical Devices segment. The Prescription Medications segment consists of operations related to vacuum erection devices, which are sold domestically and internationally.